Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial.
Year: 2023
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Simon Heeke, Saumil Gandhi, Hai T. Tran, Vincent K. Lam, Lauren Averett Byers, Don Lynn Gibbons, Carl Michael Gay, Mehmet Altan, Mara Antonoff, Xiuning Le, Janet Chen Tu, Michelle Pek, Jonathan Poh, Kao Chin Ngeow, Anne S. Tsao, Tina Cascone, Marcelo Vailati Negrao, George R. Blumenschein, John Heymach, Yasir Y Elamin
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4379280861